The standard to come: systemic therapies for systemic disease
- PMID: 9166473
The standard to come: systemic therapies for systemic disease
Comment on
-
Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.Cancer J Sci Am. 1995 Sep-Oct;1(3):222-9. Cancer J Sci Am. 1995. PMID: 9166480 Clinical Trial.